Preview

Medical Immunology (Russia)

Advanced search

IMBALANCE OF IL -1β И IL -1RA CYTOKINES IN BLOOD SERUM AND BRONCHOALVEOLAR LAVAGE IN COPD PATIENTS

https://doi.org/10.15789/1563-0625-2006-5-6-667-672

Abstract

Abstract. The aim of present study was to determine levels of IL-1β and its inhibitor, IL-1ra in blood serum and bronchoalveolar lavage fluid (BALF) of 20 patients with COPD, depending on severity of their disease, activity of inflammatory process, bacterial and viral complication. Methods. Twenty male patients with COPD (stage 2 to 4) were examined. It was shown that all the patients with COPD displayed high levels of IL-1β, both in the area of inflammation, and in blood serum. The latter index was dependent on the severity of disease and activity of inflammatory process. In BALF, the contents of IL-1β in all the patients under study was significantly exceeded the normal levels of this cytokine even at the earliest stages of evolving COPD. concentration in serum was depended at stage of disease and activity of inflammatory procces. There were no differences in IL-1β concentrations in BALF of 2 - 4 stage COPD patients. IL-1ra levels in the patients’ serum were within normal levels, and tended to increase in BAL, thus causing imbalanced IL-1ra/IL-1β ratio both in the inflammatory area, as well as systemically. The maximal detection of respiratory pathogens did significantly correlate with decreased IL-1ra/ IL-1β ratio, thus confirming the data on infectious agents as a pathogenetic component in COPD.

About the Authors

E. A. Surkova
НИИ пульмонологии Санкт-Петербургского государственного Медицинского университета им. И.П. Павлова, Санкт-Петербург
Russian Federation


N. A. Kuzubova
НИИ пульмонологии Санкт-Петербургского государственного Медицинского университета им. И.П. Павлова, Санкт-Петербург
Russian Federation


T. P. Ses
НИИ пульмонологии Санкт-Петербургского государственного Медицинского университета им. И.П. Павлова, Санкт-Петербург
Russian Federation


T. S. Sologub
НИИ пульмонологии Санкт-Петербургского государственного Медицинского университета им. И.П. Павлова, Санкт-Петербург
Russian Federation


Yu. V. Reztsova
НИИ пульмонологии Санкт-Петербургского государственного Медицинского университета им. И.П. Павлова, Санкт-Петербург
Russian Federation


N. V. Yakovleva
НИИ пульмонологии Санкт-Петербургского государственного Медицинского университета им. И.П. Павлова, Санкт-Петербург
Russian Federation


N. V. Egorova
НИИ пульмонологии Санкт-Петербургского государственного Медицинского университета им. И.П. Павлова, Санкт-Петербург
Russian Federation


References

1. Авдеев С.Н. Обострение ХОБЛ: значение инфекционного фактора и антибактериальная терапия. // РМЖ. – 2003. – Т.11. – № 22. – С.1205-1211.

2. Бактериологические исследования в кн.: Пневмология в пожилом и старческом возрасте. // Рук. для врачей под ред. А.Н.Кокосова. – МЕД МАСС МЕДИА, 2005. – С.163-168.

3. Шмелев Е.И. Хроническая обструктивная болезнь легких. Москва, 2003. – 112 с.

4. Abdelaziz M., Devalia J., Khair O., Calderon M., Sapsford R., Davies R. The effect of conditioned medium from cultured human bronhial epithelial cells on eosinohil and neutrophil chemotaxis and adherence in vitro //Am. J. Respir. Cell Mol. Biol. – 1995. – Vol.13. - P.728-737.

5. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation // J. Immunol. – 1995. – Vol.154. – P.2434-2440.

6. Chung K.F. Cytokines in chronic obstructive pulmonary disease // Eur. Resp. J. – 2001. – Vol.34. – P.50-59.

7. Coulter K., Wewers M., Lowe M., Knoell D. Extracellular regulation of interleukin (IL-1β) through lung epithelial cells and defective IL-1 type II receptor expression // Am. J. Respir. Cell Mol. Biol. – 1999. – Vol.20. – P.964-975.

8. Joos L., McIntyre L., RuanJ., Connet J., Anthonisen N., Weir T., Pare P., Sandford A. Association of IL-1β and IL-1receptor antogonist galotypes with rate of ecline in lung function in smokers // Thorax – 2001. – Vol.56. – P.863-866.

9. Lappalainen U., Whitsett J., Wert S., Tichelaar W., Bry K. Interleukin -1β causes pulmonary inflammation, emphysema, and airway remodeling in adult murine lung // Amer. J. of Resp. Cell and Mol. Biol. – 2005. – Vol.32. – P.311-318.

10. Oudijk , Nijhuis EH, Zwank MD, van de Graaf EA, Mager HJ, Coffer PJ, Lammers JW, Koenderman L. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils // Thorax. – 2005. – Vol.60. – P.538-544.

11. Park W., Goodman R., Steinberg K., Ruzinski J., Radella F., Park D., Pugin J., Skererrett S., Hudson L., Martin T. Cytokine balance in the lungs of patients with acute respiratory distress syndrom // Am.J. of Respir. And Crit. Care Med. – 2001. – Vol.164. – P.1896-1903.

12. Pujol J., Cosso B., Daures J. Interleukin –1 release by alveolar macrophages in asthmatic patients and healthy subjects // Int. Arch. Allergy Appl. Immunol. –1990. – Vol.91. – P.207-210.

13. Rupp J., Kothe H., Mueller A. Maass M., Dalhoff K. Imbalanced secretion of IL-1 and IL-1RA in Chlamidia pneumoiae-infected mononuclear cells from COD patients // Eur. Resp. J. – 2004. – Vol.22. – P.274-279.

14. Tsang Y., Neelamegham S., HuY. Synergy between L-selectin signalic and chemotactic activation during neutrophil adhesion and transmigration //J. Immunol. – 1997. – Vol.159. – P.4566-4577.

15. Tsao T., Hong J., Li L., Hsieh M, Liao S., Chang K. Imbalance between tumor necrosis factor-α and its soluble forms, and interleukin -1β and interleukin-1βrecrptor antagonist in BAL fluid of cavitary pulmonary tuberculosis // Chest. – 2000. – Vol.117. – P.103-109.

16. Yang Y., Bin W., Aksoy M., Kelsen S. Regulation of interleukin-1β inhibitor release by human airway epithelial cells// Eur. resp. J. – 2004. – Vol. 24. – P.360-366.


Review

For citations:


Surkova E.A., Kuzubova N.A., Ses T.P., Sologub T.S., Reztsova Yu.V., Yakovleva N.V., Egorova N.V. IMBALANCE OF IL -1β И IL -1RA CYTOKINES IN BLOOD SERUM AND BRONCHOALVEOLAR LAVAGE IN COPD PATIENTS. Medical Immunology (Russia). 2006;8(5-6):667-672. (In Russ.) https://doi.org/10.15789/1563-0625-2006-5-6-667-672

Views: 902


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)